-
EP2757376
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2757376
| EP2757376 - MOLECULAR MARKER FOR EARLY INDENTIFICATION OF PLEURAL MESOTHELIOMA PATIENTS, AND EXPRESSION ANALYSIS METHOD FOR SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.09.2017 Database last updated on 13.11.2024 | |
| Former | Examination is in progress Status updated on 16.12.2016 | Most recent event Tooltip | 01.09.2017 | Application deemed to be withdrawn | published on 04.10.2017 [2017/40] | Applicant(s) | For all designated states National University Corporation Nagoya University 1 Furo-cho Chikusa-ku Nagoya-shi Aichi 464-8601 / JP | For all designated states Medical and Biological Laboratories Co., Ltd. 5-3, Sakae 4-chome Naka-ku Nagoya-shi Aichi 460-0008 / JP | For all designated states Oncomics Co., Ltd. 2-22-8, Chikusa Chikusa-ku Nagoya-shi Aichi 464-0858 / JP | [2014/30] | Inventor(s) | 01 /
YANAGISAWA, Kiyoshi c/o National University Corporation Nagoya University 1 Furo-cho Chikusa-ku Nagoya-shi Aichi 464-8601 / JP | 02 /
TAKAHASHI, Takashi c/o National University Corporation Nagoya University 1 Furo-cho Chikusa-ku Nagoya-shi Aichi 464-8601 / JP | 03 /
YOKOI, Kohei c/o National University Corporation Nagoya University 1 Furo-cho Chikusa-ku Nagoya-shi Aichi 464-8601 / JP | 04 /
HASEGAWA, Yoshinori c/o National University Corporation Nagoya University 1 Furo-cho Chikusa-ku Nagoya-shi Aichi 464-8601 / JP | 05 /
ONO, Ken-ichiro c/o MEDICAL&BIOLOGICAL LABORATORIES CO. LTD. 1063-103 Terasawaoka Ina-shi Nagano 396-0002 / JP | 06 /
YAGI, Kasumi c/o MEDICAL&BIOLOGICAL LABORATORIES CO. LTD. 1063-103 Terasawaoka Ina-shi Nagano 396-0002 / JP | 07 /
MASUDA, Hitomi c/o MEDICAL&BIOLOGICAL LABORATORIES CO. LTD. 1063-103 Terasawaoka Ina-shi Nagano 396-0002 / JP | 08 /
TAKEUCHI, Toshiyuki c/o Oncomics Co. Ltd. 2-22-8 Chikusa Chikusa-ku Nagoya-shi Aichi 464-0858 / JP | [2014/30] | Representative(s) | Kador & Partner Part mbB Corneliusstraße 15 80469 München / DE | [N/P] |
| Former [2014/30] | Kador & Partner Corneliusstrasse 15 80469 München / DE | Application number, filing date | 12831729.4 | 14.09.2012 | WO2012JP05878 | Priority number, date | JP20110202463 | 15.09.2011 Original published format: JP 2011202463 | [2014/30] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013038696 | Date: | 21.03.2013 | Language: | JA | [2013/12] | Type: | A1 Application with search report | No.: | EP2757376 | Date: | 23.07.2014 | Language: | EN | [2014/30] | Type: | A9 Corrected patent application | No.: | EP2757376 | Date: | 26.11.2014 | [2014/48] | Search report(s) | International search report - published on: | JP | 21.03.2013 | (Supplementary) European search report - dispatched on: | EP | 29.04.2015 | Classification | IPC: | G01N33/574, C07K14/47, C07K16/18, C12N15/09 | [2014/30] | CPC: |
C07K16/18 (EP,CN,US);
G01N33/57407 (EP,CN,US);
G01N33/57423 (US);
C07K14/47 (EP,CN,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/30] | Title | German: | MOLEKULARER MARKER ZUR FRÜHEN ERKENNUNG VON PLEURAMESOTHELIOM-PATIENTEN UND EXPRESSIONSANALYSEVERFAHREN DAFÜR | [2014/30] | English: | MOLECULAR MARKER FOR EARLY INDENTIFICATION OF PLEURAL MESOTHELIOMA PATIENTS, AND EXPRESSION ANALYSIS METHOD FOR SAME | [2014/30] | French: | MARQUEUR MOLÉCULAIRE POUR L'IDENTIFICATION PRÉCOCE DE PATIENTS SOUFFRANT DE MÉSOTHÉLIOME PLEURAL ET PROCÉDÉ D'ANALYSE D'EXPRESSION ASSOCIÉ | [2014/30] | Entry into regional phase | 11.04.2014 | Translation filed | 11.04.2014 | National basic fee paid | 11.04.2014 | Search fee paid | 11.04.2014 | Designation fee(s) paid | 11.04.2014 | Examination fee paid | Examination procedure | 11.04.2014 | Examination requested [2014/30] | 04.11.2015 | Amendment by applicant (claims and/or description) | 16.12.2016 | Despatch of a communication from the examining division (Time limit: M04) | 27.04.2017 | Application deemed to be withdrawn, date of legal effect [2017/40] | 23.05.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/40] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.12.2016 | Fees paid | Renewal fee | 29.09.2014 | Renewal fee patent year 03 | 29.09.2015 | Renewal fee patent year 04 | 22.09.2016 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO03016471 (DANA FARBER CANCER INST INC [US], et al) [X] 8-12,14 * abstract * [Y] 1-7,13,15; | [Y]WO2011024114 (ECOLE POLYTECH [CH], et al) [Y] 9-11,13,15 * page 32, paragraph 3; claims 1-27; sequence 1 *; | [XY] - SCHRAMM ALEXANDRA ET AL, "Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.", EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY : OFFICIAL JOURNAL OF THE EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY MAR 2010, (201003), vol. 37, no. 3, ISSN 1873-734X, pages 566 - 572, XP002737570 [X] 8,12,14 * abstract * * page 567, column r, paragraph 1 * [Y] 1-7,9-11,13,15 DOI: http://dx.doi.org/10.1016/j.ejcts.2009.08.027 | [XP] - LAURA MORRA ET AL, "Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update", VIRCHOWS ARCHIV, SPRINGER, BERLIN, DE, (20111014), vol. 459, no. 5, doi:10.1007/S00428-011-1151-5, ISSN 1432-2307, pages 465 - 475, XP019970698 [XP] 1-15 * the whole document * DOI: http://dx.doi.org/10.1007/s00428-011-1151-5 | International search | [A]JP2005500059 (DANA-FARBER CANCER INSTITUTE, INC.); | [X] - ALEXANDRA SCHRAMM, "Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma", EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, (2010), vol. 37, pages 566 - 572, XP026928544 DOI: http://dx.doi.org/10.1016/j.ejcts.2009.08.027 | [A] - CORINNE DAHINDEN, "Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer", CLINICAL CANCER RESEARCH, (2010), vol. 16, no. 1, pages 88 - 98, XP055148412 | [A] - ALEX SOLTERMANN, "Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal- Epithelial Transition Protein Expression in Non-Small Cell Lung Cancer", CLINICAL CANCER RESEARCH, (2008), vol. 14, no. 22, pages 7430 - 7437, XP055072348 DOI: http://dx.doi.org/10.1158/1078-0432.CCR-08-0935 | [XP] - LAURA MORRA, "Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update", VIRCHOWS ARCH, (201110), vol. 459, pages 465 - 475, XP019970698 DOI: http://dx.doi.org/10.1007/s00428-011-1151-5 | by applicant | WO2007077934 | WO2009001940 | - FUJIMOTO N. ET AL., J. CANCER RES. CLIN. ONCOL., (2010), vol. 136, page 1755 | - HUSAIN ET AL., ARCH. PATHOL. LAB. MED., (2009), vol. 133, page 1317 | - TAKESHITA S. ET AL., BIOCHEM. J., (1993), vol. 294, page 271 | - SASAKI H. ET AL., JPN. J. CANCER RES., (2001), vol. 92, page 869 | - SASAKI H. ET AL., CANCER, (2001), vol. 92, page 843 | - SHAO R. ET AL., MOL. CELL BIOL., (2004), vol. 24, page 3992 | - SASAKI H. ET AL., CANCER LETT., (2001), vol. 172, page 37 | - BARIL P. ET AL., ONCOGENE, (2007), vol. 26, page 2082 | - PORCEL J. M.; LIGHT R. W., AM. FAM. PHYSICIAN., (2006), vol. 73, page 1211 |